Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod vs LEEP for CIN 2-3
NCT02130323Phase 3Completed
- Sponsor
- Naval Medical Center San Diego
- Start
- Feb 2015
- Primary completion
- Dec 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in cervical intraepithelial neoplasia (CIN), sponsored by Naval Medical Center San Diego. Started Feb 2015; status: completed.
02
Drugs
imiquimod
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT02130323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130323.